Hearing monitoring in adults individuals undergoing chemotherapy process with carboplatin

• Grant number: 14/17737-9
• Support Opportunities: Scholarships in Brazil - Scientific Initiation
• Start date: December 01, 2014
• End date: November 30, 2015
• Field of knowledge: Health Sciences - Speech Therapy
• Principal Investigator: Daniela Gil
• Grantee: Priscila Ivanchuk Damian
• Host Institution: Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil

Abstract

Hearing is one of the human senses that adds quality to an individual's life. It is also through it that oral speech - the most common form of communication - develops and settles itself. The frequencies in speech are in between the range 300 Hz to 4.000 Hz. Thus lays the importance of the individual with a normal hearing spectrum: the non loss of his oral communication. There are several causes of hearing loss and among them is ototoxicity. Ototoxicity is a direct result of ototoxic drugs, such as antibiotics, loop diuretics and anticancer drugs. The resulting hearing loss from ototoxicity of anticancer is irreversible. Primarily involving the base of the cochlea as a first side effect, the hearing loss will be seen in the higher frequencies. Nowadays there are a few studies of hearing monitoring in adults which bases this current study's importance. This study purpose is gaining insight in the adult patient's hearing undergoing the chemotherapy process with carboplatina through audiological tests.